Search Results 81 – 100 of 154
Limitations to Treatment Safety and Efficacy
Adherence to the Continuum of Care
Appendix A: Key to Acronyms
Adverse Effects of Antiretroviral Agents
Drug Name Abbreviations
Cost Considerations and Antiretroviral Therapy
General Terms
Study and Trial Names
Appendix B: Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy
Drug-Drug Interactions
Overview: Drug-Drug Interactions between Antiretrovirals and Other Drugs
Drug-Drug Interactions: Protease Inhibitors and Other Drugs
Table 14. Antiretroviral Drug Use in Pregnant People With HIV: Pharmacokinetic and Toxicity Data in Human Pregnancy and Recommendations for Use in Pregnancy | Overview
Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors
Abacavir (Ziagen, ABC)
Drug-Drug Interactions: Non-Nucleoside Reverse Transcriptase Inhibitors and Other Drugs
Non-Nucleoside Reverse Transcriptase Inhibitors
Drug-Drug Interactions: Nucleoside Reverse Transcriptase Inhibitors and Other Drugs
Emtricitabine (Emtriva, FTC)
Doravirine (Pifeltro, DOR)